New Key Statistics Module, Z-Score and F-Score
NAS:KROS Key Ratios
| Market Cap $ M | 2,064.52 |
| Enterprise Value $ M | 1,765.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.49 |
| Price/Sales | 11,464.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -5.20 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -96.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.57 |
| EV-to-EBITDA | -11.63 |
| PEG | -- |
| Shares Outstanding M | 36.07 |
| Net Margin (%) | -101,319.21 |
| Operating Margin % | -110,954.31 |
| Pre-tax Margin (%) | -101,319.21 |
| Quick Ratio | 14.25 |
| Current Ratio | 14.25 |
| ROA % (ttm) | -43.87 |
| ROE % (ttm) | -48.21 |
| ROIC % (ttm) | -599.93 |
| Dividend Yield % | -- |
| Altman Z-Score | 30.47 |
KROS Number of Guru Trades
KROS Volume of Guru Trades
Gurus Latest Trades with NAS:KROS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KROS is held by these investors
Total 1
Keros Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KROS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers